Grants and Contracts Details
The goal of this trial is to assess the effect of a stepped dose treatment of resveratrol on putative biomarkers of Alzheimer’s disease (AD); to assess the safety and tolerability of treatment with resveratrol over a 12-month period in participants with mild to moderate AD; and to assess the effect of a stepped dose treatment of resveratrol on rate of whole-brain and hippocampal atrophy, as well as regional cortical thinning, using volumetric magnetic resonance imaging (MRI). Each site is expected to enroll 4-5 subjects. There is no maximum enrollment, however, you must obtain permission from the ADCS RES Project Management team prior to enrolling subjects beyond the contract amount. Ensure a current, fully executed Trial Protocol Attachment [TPA] is on file.
|Effective start/end date||11/1/11 → 6/30/13|
- University of California San Diego Health: $5,200.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.